Semafore Pharmaceuticals raises $9.5 million in financing

Semafore Pharmaceuticals Inc. has raised $9.5 million in equity partly to finance Phase I clinical tests of its cancer treatment.

The start-up Indianapolis drug developer said both existing and new investors were involved in the infusion, and that the funding would be paired with $4 million received last year from the state’s 21st Century Research and Technology Fund, the Cancer Treatment Research Foundation and the Multiple Myeloma Research Foundation.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.